The value of metabolic surgery for patients with obesity and type 2 diabetes in Romania
Frontiers in Nutrition · 07.10.2025 · 12
DOI: 10.3389/fnut.2025.1624280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 07.10.2025. Verfasst von Gábor Kovács und 16 weiteren Autor:innen. Beteiligte Einrichtung: Syreon Research Institute, Budapest, Hungary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Metabolic surgery is a well-established intervention for managing severe obesity and type 2 diabetes, offering significant long-term health benefits. In Europe, procedures such as sleeve gastrectomy and Roux-en-Y gastric bypass have been shown to improve glycemic control, reduce obesity-related comorbidities, and enhance quality of life. Given the high prevalence of obesity in Romania, evaluating the cost-effectiveness of these surgical interventions is crucial for potential public funding inclusion.
Methods
We adapted a Central European type 2 diabetes—metabolic surgery cost-utility model using Romanian epidemiological and healthcare cost data to assess the cost-effectiveness of weight-loss surgery. The model incorporated three Body Mass Index strata (30–34.9, 35–39.9, ≥40 kg/m 2 ) and tracked outcomes over a lifetime horizon. Cost and quality-adjusted life years were evaluated for sleeve gastrectomy and Roux-en-Y gastric bypass using two costing methodologies: Diagnosis-Related Group-based reimbursement and micro-costing analysis. Scenario analyses, including threshold analysis, were conducted to validate model robustness.
Results
Obesity surgery was found to be a dominant strategy, yielding both cost savings and improved health outcomes across all Body Mass Index categories. The intervention led to increased life expectancy, reduced diabetes-related complications, and a significant reduction in healthcare costs. Even under conservative cost assumptions, the surgery remained cost-effective, with an Incremental Cost-Effectiveness Ratio (ICER) well within European funding thresholds.
Conclusion
The results support the inclusion of metabolic surgery in Romania’s public healthcare system. Expanding access could reduce long-term healthcare expenditures while improving the quality of life for individuals with obesity and type 2 diabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Syreon Research Institute, Budapest, Hungary.
- Syreon Research Romania, Târgu Mureș, Romania.
- Faculty of Economics and Business Administration, Babeș-Bolyai University, Cluj Napoca, Romania.
- Institutul Național de Endoscrinologie C.I. Parhon, Bucharest, Romania.
- Pathophysiology Department, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- University of Medicine and Pharmacy "V. Babes", Timișoara, Romania.
Zitieren
APA
Kovács, G., Lorenzovici, L., Poiană, C., Catoi, A. F., Duta, C., Timofte, D. V., Coros, M. F., Siménfalvi, S., Farkas-Ráduly, S., Török, T., Jakab, A. T., Kacsó, A., Nagy, L., Imre, L., Nagy, D., Copaescu, C. A., & Pana, B. C. (2025). The value of metabolic surgery for patients with obesity and type 2 diabetes in Romania. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1624280
Vancouver
Kovács G, Lorenzovici L, Poiană C, Catoi AF, Duta C, Timofte DV, et al. The value of metabolic surgery for patients with obesity and type 2 diabetes in Romania. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1624280
BibTeX
@article{Kovcs2025,
author = {Kovács, Gábor and Lorenzovici, László and Poiană, Cătălina and Catoi, Adriana Florinela and Duta, Ciprian and Timofte, Daniel Vasile and Coros, Marius Florin and Siménfalvi, Sándor and Farkas-Ráduly, Szabolcs and Török, Tamás and Jakab, Andrea Timea and Kacsó, Andrea and Nagy, László and Imre, László and Nagy, Dávid and Copaescu, Catalin Andu and Pana, Bogdan Cristian},
title = {The value of metabolic surgery for patients with obesity and type 2 diabetes in Romania},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1624280}
}
EUVIMED